{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:26:48Z","timestamp":1790249208516,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s10549-011-1796-4","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T06:35:43Z","timestamp":1317018943000},"page":"333-340","source":"Crossref","is-referenced-by-count":17,"title":["The BRCA2 c.9004G&gt;A (E2003K) variant is likely pathogenic and recurs in breast and\/or ovarian cancer families of French Canadian descent"],"prefix":"10.1007","volume":"131","author":[{"given":"Stephanie","family":"Cote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna L.","family":"Arcand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Nolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Ghadirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia N.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"issue":"9","key":"1796_CR1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665\u2013676. doi: 10.1038\/nrc1431","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1796_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/bcr1865","volume":"10","author":"E Lee","year":"2008","unstructured":"Lee E, McKean-Cowdin R, Ma H, Chen Z, Van Den Berg D, Henderson BE, Bernstein L, Ursin G (2008) Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients. Breast Cancer Res 10(1):19. doi: 10.1186\/bcr1865","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1796_CR3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2007.14.4154","volume":"26","author":"S Domchek","year":"2008","unstructured":"Domchek S, Weber BL (2008) Genetic variants of uncertain significance: flies in the ointment. J Clin Oncol 26(1):16\u201317. doi: 10.1200\/JCO.2007.14.4154","journal-title":"J Clin Oncol"},{"issue":"4","key":"1796_CR4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10689-010-9372-3","volume":"9","author":"L Cavallone","year":"2010","unstructured":"Cavallone L, Arcand SL, Maugard CM, Nolet S, Gaboury LA, Mes-Masson AM, Ghadirian P, Provencher D, Tonin PN (2010) Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer. Fam Cancer 9(4):507\u2013517. doi: 10.1007\/s10689-010-9372-3","journal-title":"Fam Cancer"},{"issue":"7","key":"1796_CR5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nsmb.2096","volume":"18","author":"WK Holloman","year":"2011","unstructured":"Holloman WK (2011) Unraveling the mechanism of BRCA2 in homologous recombination. Nat Struct Mol Biol 18(7):748\u2013754. doi: 10.1038\/nsmb.2096","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"1796_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y","volume":"16","author":"C Szabo","year":"2000","unstructured":"Szabo C, Masiello A, Ryan JF, Brody LC (2000) The breast cancer information core: database design, structure, and scope. Hum Mutat 16(2):123\u2013131. doi: 10.1002\/1098-1004(200008)16:2<123:AID-HUMU4>3.0.CO;2-Y","journal-title":"Hum Mutat"},{"issue":"1","key":"1796_CR7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2005.03.006","volume":"233","author":"R Salazar","year":"2006","unstructured":"Salazar R, Cruz-Hernandez JJ, Sanchez-Valdivieso E, Rodriguez CA, Gomez-Bernal A, Barco E, Fonseca E, Portugal T, Gonzalez-Sarmiento R (2006) BRCA1\u20132 mutations in breast cancer: identification of nine new variants of BRCA1\u20132 genes in a population from central Western Spain. Cancer Lett 233(1):172\u2013177. doi: 10.1016\/j.canlet.2005.03.006","journal-title":"Cancer Lett"},{"issue":"5","key":"1796_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IF Fokkema","year":"2011","unstructured":"Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT (2011) LOVD v.2.0: the next generation in gene variant databases. Hum Mutat 32(5):557\u2013563. doi: 10.1002\/humu.21438","journal-title":"Hum Mutat"},{"issue":"5","key":"1796_CR9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/302099","volume":"63","author":"PN Tonin","year":"1998","unstructured":"Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63(5):1341\u20131351. doi: 10.1086\/302099","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1796_CR10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ijc.20406","volume":"112","author":"KK Oros","year":"2004","unstructured":"Oros KK, Ghadirian P, Greenwood CM, Perret C, Shen Z, Paredes Y, Arcand SL, Mes-Masson AM, Narod SA, Foulkes WD, Provencher D, Tonin PN (2004) Significant proportion of breast and\/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int J Cancer 112(3):411\u2013419. doi: 10.1002\/ijc.20406","journal-title":"Int J Cancer"},{"issue":"4","key":"1796_CR11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1399-0004.2006.00673.x","volume":"70","author":"KK Oros","year":"2006","unstructured":"Oros KK, Ghadirian P, Maugard CM, Perret C, Paredes Y, Mes-Masson AM, Foulkes WD, Provencher D, Tonin PN (2006) Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and\/or ovarian cancer families of French Canadian descent. Clin Genet 70(4):320\u2013329. doi: 10.1111\/j.1399-0004.2006.00673.x","journal-title":"Clin Genet"},{"key":"1796_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2350-7-23","volume":"7","author":"KK Oros","year":"2006","unstructured":"Oros KK, Leblanc G, Arcand SL, Shen Z, Perret C, Mes-Masson AM, Foulkes WD, Ghadirian P, Provencher D, Tonin PN (2006) Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and\/ovarian cancer families. BMC Med Genet 7:23. doi: 10.1186\/1471-2350-7-23","journal-title":"BMC Med Genet"},{"issue":"2","key":"1796_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000053364","volume":"52","author":"AP Manning","year":"2001","unstructured":"Manning AP, Abelovich D, Ghadirian P, Lambert JA, Frappier D, Provencher D, Robidoux A, Peretz T, Narod SA, Mes-Masson AM, Foulkes WD, Wang T, Morgan K, Fujiwara TM, Tonin PN (2001) Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered 52(2):116\u2013120","journal-title":"Hum Hered"},{"issue":"9","key":"1796_CR14","first-page":"841","volume":"93","author":"PN Tonin","year":"2006","unstructured":"Tonin PN (2006) The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada. Bull Cancer 93(9):841\u2013846","journal-title":"Bull Cancer"},{"key":"1796_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.genom.2.1.69","volume":"2","author":"CR Scriver","year":"2001","unstructured":"Scriver CR (2001) Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2:69\u2013101. doi: 10.1146\/annurev.genom.2.1.69","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"1796_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.2005.00497.x","volume":"68","author":"AM Laberge","year":"2005","unstructured":"Laberge AM, Michaud J, Richter A, Lemyre E, Lambert M, Brais B, Mitchell GA (2005) Population history and its impact on medical genetics in Quebec. Clin Genet 68(4):287\u2013301. doi: 10.1111\/j.1399-0004.2005.00497.x","journal-title":"Clin Genet"},{"issue":"2\u20133","key":"1796_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00439-005-1297-9","volume":"117","author":"H Vezina","year":"2005","unstructured":"Vezina H, Durocher F, Dumont M, Houde L, Szabo C, Tranchant M, Chiquette J, Plante M, Laframboise R, Lepine J, Nevanlinna H, Stoppa-Lyonnet D, Goldgar D, Bridge P, Simard J (2005) Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French\u2013Canadian breast\/ovarian cancer families. Hum Genet 117(2\u20133):119\u2013132. doi: 10.1007\/s00439-005-1297-9","journal-title":"Hum Genet"},{"issue":"2","key":"1796_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmg.2006.044388","volume":"44","author":"J Simard","year":"2007","unstructured":"Simard J, Dumont M, Moisan AM, Gaborieau V, Malouin H, Durocher F, Chiquette J, Plante M, Avard D, Bessette P, Brousseau C, Dorval M, Godard B, Houde L, Joly Y, Lajoie MA, Leblanc G, Lepine J, Lesperance B, Vezina H, Parboosingh J, Pichette R, Provencher L, Rheaume J, Sinnett D, Samson C, Simard JC, Tranchant M, Voyer P, Easton D, Tavtigian SV, Knoppers BM, Laframboise R, Bridge P, Goldgar D (2007) Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French\u2013Canadian families with high risk of breast and ovarian cancer. J Med Genet 44(2):107\u2013121. doi: 10.1136\/jmg.2006.044388","journal-title":"J Med Genet"},{"issue":"5","key":"1796_CR19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1399-0004.2009.01277.x","volume":"76","author":"P Ghadirian","year":"2009","unstructured":"Ghadirian P, Robidoux A, Zhang P, Royer R, Akbari M, Zhang S, Fafard E, Costa M, Martin G, Potvin C, Patocskai E, Larouche N, Younan R, Nassif E, Giroux S, Narod SA, Rousseau F, Foulkes WD (2009) The contribution of founder mutations to early-onset breast cancer in French\u2013Canadian women. Clin Genet 76(5):421\u2013426. doi: 10.1111\/j.1399-0004.2009.01277.x","journal-title":"Clin Genet"},{"issue":"3","key":"1796_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-007-9608-6","volume":"108","author":"SL Arcand","year":"2008","unstructured":"Arcand SL, Maugard CM, Ghadirian P, Robidoux A, Perret C, Zhang P, Fafard E, Mes-Masson AM, Foulkes WD, Provencher D, Narod SA, Tonin PN (2008) Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families. Breast Cancer Res Treat 108(3):399\u2013408. doi: 10.1007\/s10549-007-9608-6","journal-title":"Breast Cancer Res Treat"},{"key":"1796_CR21","doi-asserted-by":"crossref","unstructured":"Cancer risks in BRCA2 mutation carriers. The breast cancer linkage consortium (1999). J Natl Cancer Inst 91 (15):1310\u20131316","DOI":"10.1093\/jnci\/91.15.1310"},{"issue":"R6","key":"1796_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9(R6):83. doi: 10.1186\/bcr1828","journal-title":"Breast Cancer Res"},{"issue":"16","key":"1796_CR23","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1073\/pnas.0701724104","volume":"104","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD (2007) Analysis of PALB2\/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104(16):6788\u20136793. doi: 10.1073\/pnas.0701724104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1796_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","volume":"76","author":"HT Lynch","year":"2009","unstructured":"Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76(1):1\u201318. doi: 10.1111\/j.1399-0004.2009.01230.x","journal-title":"Clin Genet"},{"issue":"4","key":"1796_CR25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10689-007-9152-x","volume":"6","author":"PN Tonin","year":"2007","unstructured":"Tonin PN, Maugard CM, Perret C, Mes-Masson AM, Provencher DM (2007) A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families. Fam Cancer 6(4):491\u2013497. doi: 10.1007\/s10689-007-9152-x","journal-title":"Fam Cancer"},{"issue":"3","key":"1796_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1097-0215(20010520)95:3<189::AID-IJC1032>3.0.CO;2-N","volume":"95","author":"PN Tonin","year":"2001","unstructured":"Tonin PN, Perret C, Lambert JA, Paradis AJ, Kantemiroff T, Benoit MH, Martin G, Foulkes WD, Ghadirian P (2001) Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history. Int J Cancer 95(3):189\u2013193","journal-title":"Int J Cancer"},{"issue":"5588","key":"1796_CR27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","volume":"297","author":"H Yang","year":"2002","unstructured":"Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thoma NH, Zheng N, Chen PL, Lee WH, Pavletich NP (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297(5588):1837\u20131848. doi: 10.1126\/science.297.5588.1837","journal-title":"Science"},{"issue":"7035","key":"1796_CR28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035):917\u2013921. doi: 10.1038\/nature03445","journal-title":"Nature"},{"issue":"7035","key":"1796_CR29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434(7035):913\u2013917. doi: 10.1038\/nature03443","journal-title":"Nature"},{"issue":"7182","key":"1796_CR30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nature06548","volume":"451","author":"SL Edwards","year":"2008","unstructured":"Edwards SL, Brough R, Lord CJ, Natrajan R, Vatcheva R, Levine DA, Boyd J, Reis-Filho JS, Ashworth A (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451(7182):1111\u20131115. doi: 10.1038\/nature06548","journal-title":"Nature"},{"key":"1796_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4137\/CIN.S618","volume":"6","author":"R Karchin","year":"2008","unstructured":"Karchin R, Agarwal M, Sali A, Couch F, Beattie MS (2008) Classifying variants of undetermined significance in BRCA2 with protein likelihood ratios. Cancer Inform 6:203\u2013216","journal-title":"Cancer Inform"},{"issue":"2","key":"1796_CR32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68(2):410\u2013419. doi: 10.1086\/318181","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1796_CR33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE (2007) A systematic genetic assessment of 1, 433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873\u2013883. doi: 10.1086\/521032","journal-title":"Am J Hum Genet"},{"issue":"19","key":"1796_CR34","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1158\/0008-5472.CAN-10-1012","volume":"70","author":"M Tischkowitz","year":"2010","unstructured":"Tischkowitz M, Xia B (2010) PALB2\/FANCN: recombining cancer and Fanconi anemia. Cancer Res 70(19):7353\u20137359. doi: 10.1158\/0008-5472.CAN-10-1012","journal-title":"Cancer Res"},{"issue":"3","key":"1796_CR35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-010-0801-7","volume":"124","author":"M Wasielewski","year":"2010","unstructured":"Wasielewski M, Out AA, Vermeulen J, Nielsen M, van den Ouweland A, Tops CM, Wijnen JT, Vasen HF, Weiss MM, Klijn JG, Devilee P, Hes FJ, Schutte M (2010) Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer. Breast Cancer Res Treat 124(3):635\u2013641. doi: 10.1007\/s10549-010-0801-7","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1796_CR36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm.1719","volume":"14","author":"SG Kuznetsov","year":"2008","unstructured":"Kuznetsov SG, Liu P, Sharan SK (2008) Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med 14(8):875\u2013881. doi: 10.1038\/nm.1719","journal-title":"Nat Med"},{"issue":"1","key":"1796_CR37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1096-8644(200101)114:1<30::AID-AJPA1003>3.0.CO;2-L","volume":"114","author":"A Gagnon","year":"2001","unstructured":"Gagnon A, Heyer E (2001) Fragmentation of the Quebec population genetic pool (Canada): Evidence from the genetic contribution of founders per region in the 17th and 18th centuries. Am J Phys Anthropol 114(1):30\u201341","journal-title":"Am J Phys Anthropol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1796-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1796-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1796-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T09:15:40Z","timestamp":1560676540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1796-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1796"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1796-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]}}}